본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
The effect of curative resection on fecal microbiota in patients with colorectal cancer: a prospective pilot study Kim Bun
(Center for Colorectal Cancer)

Park Sung Sil
(Department of Surgery)
. The effect of curative resection on fecal microbiota in patients with colorectal cancer: a prospective pilot study. ANNALS OF SURGICAL TREATMENT AND RESEARCH. 2020-06-29; 2020; 99(1):45~51. IF 1.367 (2019)
Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial) Park Young Lee
(Branch of Hemato Oncology)


()
. Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial). GASTRIC CANCER. 2020-06-28; 2020; Online:Published. IF 7.088 (2019)
Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance
()

Koo Ha Rim
(Cancer Proteogenomic Analysis Consortium)
. Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance. CANCERS. 2020-06-27; 2020; 12(7):1707~. IF 6.126 (2019)
The Effect of Socioeconomic Status on All-Cause Maternal Mortality: A Nationwide Population-Based Cohort Study
()

Jeong Won Jeong
(Cancer Information & Education Center)
. The Effect of Socioeconomic Status on All-Cause Maternal Mortality: A Nationwide Population-Based Cohort Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2020-06-26; 2020; 17(12):4606~. IF 2.849 (2019)
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry
()

Woo Sang Myung
(Division of Tomor Immunology)
. Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2020-06-26; 2020; Online:Published. IF 1.907 (2019)
Blockade of endothelin receptor A enhances the therapeutic efficacy of gemcitabine in pancreatic cancer cells Kim Youn Jae
(Division of Translational Science)

Ahn Hye-Mi
(Division of Translational Science)
. Blockade of endothelin receptor A enhances the therapeutic efficacy of gemcitabine in pancreatic cancer cells. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2020-06-25; 2020; 527(2):568~573. IF 2.985 (2019)
Feasibility Study of Synthetic Diffusion-Weighted MRI inPatients with Breast Cancer in Comparison with ConventionalDiffusion-Weighted MRI
()

Choi Bo Hwa
(Department of Radiology)
. Feasibility Study of Synthetic Diffusion-Weighted MRI inPatients with Breast Cancer in Comparison with ConventionalDiffusion-Weighted MRI. KOREAN JOURNAL OF RADIOLOGY. 2020-06-24; 2020; 21(9):1036~1044. IF 3.179 (2019)
The Fear of Cancer from the Standpoint of Oneself, the Opposite Sex and the Fear of Side Effects of Cancer Treatment Park Keeho
(Cancer Information & Education Center)

Park Keeho
(Cancer Information & Education Center)
. The Fear of Cancer from the Standpoint of Oneself, the Opposite Sex and the Fear of Side Effects of Cancer Treatment. CANCER RESEARCH AND TREATMENT. 2020-06-24; 2020; Online:Published. IF 3.761 (2019)
Operating protocols of a community treatment center for isolation of patients with coronavirus disease, South Korea
()

Kang EunKyo
(Division of Cancer Early Detection)
. Operating protocols of a community treatment center for isolation of patients with coronavirus disease, South Korea. EMERGING INFECTIOUS DISEASES. 2020-06-22; 2020; 26(10):2329~2337. IF 6.259 (2019)
Underwater EMR or endoscopic submucosal dissection for rectal neuroendocrine tumors: What are the advantages? -Response Han Kyung Su
(Center for Colorectal Cancer)

Park Sung Sil
(Department of Surgery)
. Underwater EMR or endoscopic submucosal dissection for rectal neuroendocrine tumors: What are the advantages? -Response. GASTROINTESTINAL ENDOSCOPY. 2020-06-22; 2020; 92(1):231~. IF 6.89 (2019)
First page Prev paging 131 132 133 134 135 136 137 138 139 140 next paging last page